Pilot Award Recipient: Jeremy Goecks, PhD
Genetic mutations in HIV have been found to impact all aspects of the disease, including overall progression, clinical outcomes and treatment efficacy, and the failure of treatments that...
The DC CFAR has funded a wide variety of research, including basic, clinical, epidemiologic, social behavioral and prevention HIV/AIDS science since 2017.
Pilot Award Recipient: Jeremy Goecks, PhD
Genetic mutations in HIV have been found to impact all aspects of the disease, including overall progression, clinical outcomes and treatment efficacy, and the failure of treatments that...
Pilot Award Recipient: Rachel Scott, MD, MPH
Washington, DC is an epicenter of the Human Immunodeficiency Virus (HIV) epidemic in the United States.
Pilot Award Recipient: Jennifer Huang Bouey, MBBS, PhD, MPH
Domestic and international migration and sexual violence are two precursors highly correlated with HIV/STI among female commercial sex workers (FCSW) worldwide.
Pilot Award Recipient: Valeria Avdoshina, MD, PhD
Human immunodeficiency virus (HIV) enters central nervous system (CNS) and causes synapto-dendritic simplification as well as motor and cognitive function alterations seen in a subset of HIV...
Pilot Award Recipient: Seble Kassaye, MD, MS
Despite ongoing HIV prevention efforts since the early days of the HIV epidemic, HIV transmission has remained steady, with an estimated 50,000 new HIV cases every year.
Pilot Award Recipient: Marc O. Siegel, MD
As the average age of the US HIV infected population has risen in the last 3 decades there is increasing concern regarding the accelerated aging that has been documented.
Pilot Award Recipient: Simeon Adesina, PhD, MSc
Our long-term goal is to design a nanoplatform for the co-delivery of anti-HIV drugs and siRNA and to target the siRNA- and drug-loaded nanoparticles to viral anatomical and cellular reservoirs.
Pilot Award Recipient: Catherine Bollard, MD
This project aims to enhance expanded HIV-specific T cells from HIV patients so that T cell therapy may ultimately be a cure for HIV, either alone or in combination with other immunotherapy...
Pilot Award Recipient: Mark Burke, PhD
Pediatric HIV infection remains a global health crisis with a worldwide infection rate of 2.5 million (WHO, Geneva Switzerland, 2009).
Pilot Award Recipient: Xiong Jiang, PhD
Due to decreases in mortality rates and increased rates of HIV infection among older adults, the prevalence of older adults (>50 years old) living with HIV has increased substantially.